Comparative Study of Therapeutic Effects of Two Medical Intervention of Citalopram 4 Hours before Coitus and Each 12 Hours in Treatment Of Premature Ejaculation

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201010304989N2

Enrollment

113

Registered

2010-12-12

Start date

2009-04-04

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premature Ejaculation. Premature Ejaculation

Interventions

Intervention 1: Citalopram, 20mg, orally, every 12 hours for 8 weeks. Intervention 2: Citalopram, 20mg, orally, 4 hours before coitus for 8 weeks.

Treatment - Drugs

Citalopram, 20mg, orally, every 12 hours for 8 weeks

Citalopram, 20mg, orally, 4 hours before coitus for 8 weeks

Eligibility

Sex/Gender

Male

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Age between 18 and 50 years, documented history of primary premature ejaculation, sexual intercourse at least once a week Exclusion criteria: Drug noncompliance, past history of pelvic or central nervous system trauma or operation

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Ejaculation time. Timepoint: Before intervention, 4 weeks after intervention, 8 weeks after intervention. Method of measurement: with chronometer.	—

Secondary

Measure	Time frame
Drug adverse effect. Timepoint: Before intervention, 4 weeks after intervention, 8 weeks after intervention. Method of measurement: Interview with patient.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Bijan Rezakhaniha

I.R.I Army University of Medical Sciences

reza.bijan@yahoo.com+98 21 2255 7435

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026